home.aspx
 
EVENTS

2nd Middle East Pharmacy and Pharmaceutical Conference
2ND MIDDLE EAST PHARMACY AND PHARMACEUTICAL CONFERENCE
December 09-10, 2019
The 2nd Middle east Pharmacy and Pharmaceutical Conference will be held amid December 09-10, 2019 at Dubai, UAE.  Pharma Conference 2019 is a worldwide stage for drug specialists, pharmaceutical advertising professional's, pharmaceutical industry experts, and analysts, researchers, clinicia...

BIOFIT 2019
BIOFIT 2019
December 10-11, 2019
With the highest attending rate of academics, TTOs and research institutions, BioFIT is the place where academia-industry collaborations get started. BioFIT has taken on a whole new dimension becoming the meeting point in Europe for tech transfer and for sourcing early-stage innovations stemming fro...

Adcock Ingram

Adcock Ingram is a leading South African pharmaceutical company with a proud 120 year heritage. It hasa portfolio of trusted, quality brands and generics and an entrenched value system that assures integrity.

RELATED NEWS


A court has backed NHS England in a case where US pharma giant AbbVie had alleged that its procurement process for hepatitis C drugs was unfair. NHS England aims to eliminate hepatitis C by 2025 using the ‘largest ever’ drug procurement process, inviting pharma companies to take part in the initiative worth almost a billion pounds over five years. But AbbVie had claimed the NHS breached its duty to treat all bidders fairly and started court proceedings last year. NHS England said the...

READ MORE

FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) ("FSD" or the "Company"), announced today that Dr. Raza Bokhari, Co-Chairman and Chief Executive Officer of FSD Pharma will participate in the Arcview Investor Forum being held April 23-25, 2019, in Vancouver. The event will feature leading public and private companies and thought leaders who are shaping the future of the industry. Dr. Bokhari will be the keynote speaker and participate in panels discussing issues affectin...
SD PHARMA INC.
READ MORE

BioNTech AG, located in Mainz, Germany, inked a deal with Munich, Germany’s MAB Discovery GmbH to acquire MAB’s operational antibody generation unit. No financial details were disclosed. BioNTech will acquire all assets, employees and “proprietary know-how” for monoclonal antibody (mAb) generation. MAB will keep ownership and all rights to its preclinical development pipeline and its existing third-party service agreements. The two companies have been collaborating for mo...

READ MORE

An experimental antibody being developed by Novartis has cut cardiovascular risk in patients who have survived a heart attack in a late-stage study. The Phase III CANTOS study met the primary endpoint showing that ACZ885 (canakinumab) reduced the risk of heart attack, stroke and cardiovascular death in people with a prior heart attack and inflammatory atherosclerosis....

READ MORE

The US Food and Drug Administration (FDA) has granted Kitov Pharmaceuticals a waiver related to the $2,038,100 new drug application filing fee for KIT-302....

READ MORE

Australian laws need to change to allow women carrying mitochondrial disease to access a ground-breaking IVF procedure so they can have healthy, biologically-related children free from this incurable and life-threatening genetic disease, according to the Australian Mitochondrial Disease Foundation....

READ MORE

EVENTS

2nd Middle East Pharmacy and Pharmaceutical Conference
2ND MIDDLE EAST PHARMACY AND PHARMACEUTICAL CONFERENCE
December 09-10, 2019
The 2nd Middle east Pharmacy and Pharmaceutical Conference will be held amid December 09-10, 2019 at Dubai, UAE.  Pharma Conference 2019 is a worldwide stage for drug specialists, pharmaceutical advertising professional's, pharmaceutical industry experts, and analysts, researchers, clinicia...

BIOFIT 2019
BIOFIT 2019
December 10-11, 2019
With the highest attending rate of academics, TTOs and research institutions, BioFIT is the place where academia-industry collaborations get started. BioFIT has taken on a whole new dimension becoming the meeting point in Europe for tech transfer and for sourcing early-stage innovations stemming fro...